APA (7th ed.) Citation

Wynn, J., Rego, S., Chandler-Brown, D., Carter, R., Talati, A., Zaretsky, M., & Trimble, A. (2025). Routine cell-free DNA prenatal screening identifies pregnancies at high risk for cystic fibrosis that may benefit from fetal therapy. Journal of Cystic Fibrosis, 24(6), 1067. https://doi.org/10.1016/j.jcf.2025.08.004

Chicago Style (17th ed.) Citation

Wynn, J., S. Rego, D. Chandler-Brown, R. Carter, A. Talati, M. Zaretsky, and A. Trimble. "Routine Cell-free DNA Prenatal Screening Identifies Pregnancies at High Risk for Cystic Fibrosis That May Benefit from Fetal Therapy." Journal of Cystic Fibrosis 24, no. 6 (2025): 1067. https://doi.org/10.1016/j.jcf.2025.08.004.

MLA (9th ed.) Citation

Wynn, J., et al. "Routine Cell-free DNA Prenatal Screening Identifies Pregnancies at High Risk for Cystic Fibrosis That May Benefit from Fetal Therapy." Journal of Cystic Fibrosis, vol. 24, no. 6, 2025, p. 1067, https://doi.org/10.1016/j.jcf.2025.08.004.